Consistently, inactivation of SOCS-3 in hepatocytes improves hepatic insulin action and steatosis in young mice, but at older age, these mice develop obesity and insulin resistance due to the activation of acute phase response and overt inflammation [103]. This evidence concerns the gene INS and obesity disorder.